Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Assets (2020 - 2026)

Core Scientific has reported Assets over the past 7 years, most recently at $3.1 billion for Q1 2026.

  • Quarterly results put Assets at $3.1 billion for Q1 2026, up 104.9% from a year ago — trailing twelve months through Mar 2026 was $3.1 billion (up 104.9% YoY), and the annual figure for FY2025 was $2.3 billion, up 59.06%.
  • Assets reached $3.1 billion in Q1 2026 per CORZ's latest filing, up from $2.3 billion in the prior quarter.
  • Across five years, Assets topped out at $3.1 billion in Q1 2026 and bottomed at $664.2 million in Q2 2024.
  • Median Assets over the past 5 years was $1.4 billion (2022), compared with a mean of $1.4 billion.
  • The largest annual shift saw Assets skyrocketed 677.6% in 2022 before it crashed 71.89% in 2023.
  • Over 5 years, Assets stood at $807.7 million in 2022, then fell by 11.83% to $712.2 million in 2023, then surged by 107.25% to $1.5 billion in 2024, then skyrocketed by 59.06% to $2.3 billion in 2025, then surged by 30.75% to $3.1 billion in 2026.
  • Business Quant data shows Assets for CORZ at $3.1 billion in Q1 2026, $2.3 billion in Q4 2025, and $2.2 billion in Q3 2025.